BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30143694)

  • 1. Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China.
    Ji M; Liu Z; Chang ET; Yu X; Wu B; Deng L; Feng Q; Wei K; Liang X; Lian S; Quan W; Wang P; Du Y; Liang Z; Xia S; Lin H; Li F; Cheng W; Chen W; Yuan Y; Ye W
    Sci Rep; 2018 Aug; 8(1):12787. PubMed ID: 30143694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early diagnosis and early treatment for liver cancer in Qidong: survival of patients and effectiveness of screening].
    Chen JG; Zhang YH; Zhu J; Lu JH; Wang JB; Sun Y; Xue XF; Lu LL; Chen YS; Wu Y; Jiang XP; Ding LL; Zhang QN; Zhu YR
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):946-951. PubMed ID: 29262514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Family history of liver cancer increases the risk of liver cancer incidence: a 20-year prospective cohort study in Qidong, China].
    Sun Y; Tu H; Lu P; Wang J; Wu Y; Zhang Q; Qian G; Chen T
    Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):752-6. PubMed ID: 25496865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.
    Wun YT; Dickinson JA
    Cochrane Database Syst Rev; 2003; (2):CD002799. PubMed ID: 12804438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A 22-year-follow-up cohort study on primary liver cancer in Haimen city of Jiangsu province].
    Huang PX; Wang N; Qian JH; Jiang F; Yang YL; Lin WY; Zhao Q; Zhao GM; Jiang QW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Oct; 38(10):1376-1379. PubMed ID: 29060983
    [No Abstract]   [Full Text] [Related]  

  • 7. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
    Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
    Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.
    Chen TH; Chen CJ; Yen MF; Lu SN; Sun CA; Huang GT; Yang PM; Lee HS; Duffy SW
    Int J Cancer; 2002 Mar; 98(2):257-61. PubMed ID: 11857416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma.
    Akahoshi H; Taura N; Ichikawa T; Miyaaki H; Akiyama M; Miuma S; Ozawa E; Takeshita S; Muraoka T; Matsuzaki T; Ohtani M; Isomoto H; Matsumoto T; Takeshima F; Nakao K
    Oncol Rep; 2010 May; 23(5):1317-23. PubMed ID: 20372846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme.
    Lee EH; Han MA; Lee HY; Jun JK; Choi KS; Park EC
    Asian Pac J Cancer Prev; 2010; 11(5):1305-10. PubMed ID: 21198282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect evaluation of the primary screening strategy for liver cancer in rural areas of China].
    Cao MM; Li H; Zha ZQ; Zhou JY; Luo PF; Gong JY; Ma HM; Sun XB; Chen WQ
    Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):990-996. PubMed ID: 36164703
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
    Chen JG; Parkin DM; Chen QG; Lu JH; Shen QJ; Zhang BC; Zhu YR
    J Med Screen; 2003; 10(4):204-9. PubMed ID: 14738659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer.
    Zhang B; Yang B
    J Med Screen; 1999; 6(2):108-10. PubMed ID: 10444731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survey of the serum hepatocellular carcinoma marker Golgi glycoprotein (GP73) among Qidong residents and correlation analysis to outcome at two-year follow-up].
    Chen JG; Zhu YR; Lu WZ; Zhang YH; Lu JH
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):780-4. PubMed ID: 23207341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of liver cancer screening results and influencing factors of urban residents in Zhejiang Province from 2013 to 2018].
    Wang YQ; Li HZ; Wang L; Zhu C; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):346-352. PubMed ID: 33730826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study on screening for primary liver cancer in high risk population of an endemic area].
    Chen JG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1991 Nov; 25(6):325-8. PubMed ID: 1726199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
    Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
    World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study.
    Zeng H; Cao M; Xia C; Wang D; Chen K; Zhu Z; Fu R; Zhang S; Zhou J; Wang H; Qi X; Dai S; Chen Y; Sun Z; Ding H; Li Q; Zhao H; Zhang X; Morze J; Ji JS; Sun F; Yu X; Qu C; Chen W
    Nat Cancer; 2023 Sep; 4(9):1382-1394. PubMed ID: 37667043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
    Mok TS; Yeo W; Yu S; Lai P; Chan HL; Chan AT; Lau JW; Wong H; Leung N; Hui EP; Sung J; Koh J; Mo F; Zee B; Johnson PJ
    J Clin Oncol; 2005 Nov; 23(31):8041-7. PubMed ID: 16258102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.